Insulin aspart, recombinant Subcutaneous and Ryneze Liquid
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Ryneze Liquid and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: chlorpheniramine / methscopolamine
Brand name:
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Rytary
- Insulin aspart, recombinant Subcutaneous-Rythmol
- Insulin aspart, recombinant Subcutaneous-Rythmol Extended Release
- Insulin aspart, recombinant Subcutaneous-Rythmol SR
- Insulin aspart, recombinant Subcutaneous-Ryvent
- Insulin aspart, recombinant Subcutaneous-Ryzodeg 70/30
- Ryneze Liquid-Insulin degludec
- Ryneze Liquid-Insulin Degludec (U-100) Prefilled Pens
- Ryneze Liquid-Insulin Degludec (U-100) Vials
- Ryneze Liquid-Insulin Degludec (U-200) Prefilled Pens
- Ryneze Liquid-Insulin degludec and liraglutide
- Ryneze Liquid-Insulin degludec and liraglutide Subcutaneous